Systemic Inflammation Is Associated with Pulmonary Hypertension in Isolated Giant Omphalocele: A Population-Based

Baptiste Teillet1, Mohamed Riadh Boukhris1,2, Rony Sfeir2,3

  • 1Department of Neonatology, Pôle Femme-Mère-Nouveau-Né, Hôpital Jeanne de Flandre, Centre Hospitalier Universitaire de Lille, F-59000 Lille, France.

Insights

A prolonged inflammatory state, marked by elevated CRP, platelets, and white blood cells, is linked to pulmonary hypertension (PH) in infants with giant omphaloceles (GO) undergoing delayed closure. This finding offers insights into PH development in this patient group.

Area of Science:

  • Pediatric Surgery
  • Neonatology
  • Cardiology

Background:

  • Giant omphalocele (GO) is a complex congenital anomaly requiring specialized management.
  • Pulmonary hypertension (PH) is a serious complication in neonates, particularly those with congenital defects.
  • The relationship between perinatal factors and PH development in isolated GO is not well understood.

Purpose of the Study:

  • To identify perinatal factors associated with the development of pulmonary hypertension (PH) in infants with isolated giant omphaloceles (GO).
  • To compare postnatal morbidities between infants with GO who developed PH and those who did not.

Main Methods:

  • Retrospective review of infants with omphalocele treated at the University Hospital of Lille (1996-2021).
  • Inclusion criteria: isolated GO involving liver, treated with delayed surgical closure.
  • Comparison of prenatal/postnatal data and morbidities between GO infants with and without PH.

Main Results:

  • 30% incidence of PH observed in 50 infants with isolated GO.
  • Prolonged inflammatory state (CRP > 15 mg/L, platelets > 500 G/L, WBC > 15 G/L for >14 days) was significantly more frequent in infants with PH (73% vs. 21%, p < 0.05).
  • No significant difference in late-onset infection rates between groups.

Conclusions:

  • A prolonged inflammatory syndrome appears to be a significant contributor to PH development in infants with isolated GO managed with delayed surgical closure.
  • Monitoring inflammatory markers may be crucial for early detection and management of PH in this vulnerable population.

Related Concept Videos

Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
265
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
33
Pleural Effusion I: Introduction01:25

Pleural Effusion I: Introduction

Pleural effusion is an abnormal fluid accumulation in the pleural cavity, a narrow space between the lungs and the chest wall. It is not a disease per se but rather a symptom or indication of an underlying disease. In normal circumstances, this space contains a small amount of fluid (5 to 15 mL), a lubricant facilitating the non-frictional movement of the pleural surfaces.
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
1.5K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.9K
Pneumothorax-II01:27

Pneumothorax-II

Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
278
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
31